How has Dyne Therapeutics, Inc.'s customer receivables and other changed year-over-year?

Dyne Therapeutics, Inc.'s customer receivables and other increased by 23.3% year-over-year, from $7.1M to $8.76M.

What is the long-term trend for Dyne Therapeutics, Inc.'s customer receivables and other?

Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s customer receivables and other has grown at a 151.9% compound annual growth rate (CAGR), from $742K to $29.86M.

Dyne Therapeutics, Inc. DYN Customer receivables and Other

Customer receivables and Other at other companies

Morgan StanleyMS

$2.52B+0.4%

Raymond James FinancialRJF

$1.81B-3.5%

Chicago Atlantic Real Estate FinanceREFI

$2.56M+388%

Customers BancorpCUBI

$2.37M+25.7%

Arbor Realty TrustABR

$35.25M+267%

Ares Management CorporationARES

$0-100%

Other financials

Income statement

See full

Operating income-$125.3M-2.4%

Net income-$120.9M-4.8%

EPS (diluted)-$0.73+30.5%

Balance sheet

See full

Cash & equivalents$753.1M+59.5%

Total debt$168.7M+623%

Total equity$865.1M+29.3%

Total assets$1.1B+49.8%

Cash flow

See full

Operating cash flow-$144.9M-36.9%

CapEx$221.0K-77.5%

Free cash flow-$145.1M-35.8%

Valuation

See full

Market cap$3.35B+153%

Returns & leverage

See full

Return on equity-58.9%-4.4pp

Debt / equity0.2×+0.2×

Current ratio19.9×-0.4×

Where this comes from

Reported directly by Dyne Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeOther.

The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dyne Therapeutics, Inc.'s customer receivables and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dyne Therapeutics, Inc.'s customer receivables and other?: Dyne Therapeutics, Inc. (DYN) reported customer receivables and other of $8.76M in Q1 2026.
How has Dyne Therapeutics, Inc.'s customer receivables and other changed year-over-year?: Dyne Therapeutics, Inc.'s customer receivables and other increased by 23.3% year-over-year, from $7.1M to $8.76M.
What is the long-term trend for Dyne Therapeutics, Inc.'s customer receivables and other?: Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s customer receivables and other has grown at a 151.9% compound annual growth rate (CAGR), from $742K to $29.86M.